Should adults with autoimmune rheumatic conditions receive updated COVID-19 vaccines?

In an Arthritis & Rheumatology investigation of information connected 60,980 U.S. adults with autoimmune rheumatic conditions who developed COVID-19 betwixt December 2020 and August 2024, those who received booster oregon updated (2023–2024) COVID-19 vaccines were little apt to beryllium hospitalized for COVID-19 than those who received lone the archetypal vaccine bid oregon were unvaccinated.